NV
Noothy Venkatesham
About Noothy Venkatesham
Noothy Venkatesham has 6 years in corporate governance. Holds Director role. Currently with 2 companies, including Innovir Biosciences Private Limited and Proxima Lifesciences Private Limited. Formerly with 2 companies, such as Clarimen Research Private Limited and Integrum Life Sciences Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Innovir Biosciences Private Limited
U24100TG2017PTC121328
|
Director | 26 Aug 2021 | 2017 | Active |
Proxima Lifesciences Private Limited
U72100TS2026PTC209595
|
Director | 13 Jan 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Clarimen Research Private Limited
U74999TG2022PTC168964
|
Director | 07 Dec 2022 | 2022 | Active |
Integrum Life Sciences Private Limited
U74999TG2017PTC119406
|
Director | 18 Jan 2020 | 2017 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Noothy Venkatesham
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Noothy Venkatesham
Noothy Venkatesham has 6 years in corporate governance. Holds Director role. Currently with 2 companies, including Innovir Biosciences Private Limited and Proxima Lifesciences Private Limited. Formerly with 2 companies, such as Clarimen Research Private Limited and Integrum Life Sciences Private Limited. Engaged in General Business. Contributes to corporate operations.
Noothy Venkatesham is associated with 2 companies as Director.
Noothy Venkatesham has expertise in General Business.
Noothy Venkatesham has 6 years in corporate governance.